BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12708483)

  • 1. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
    Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
    Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
    Saegusa M; Hashimura M; Yoshida T; Okayasu I
    Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
    Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
    Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
    Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
    J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
    Ashihara K; Saito T; Mizumoto H; Nishimura M; Tanaka R; Kudo R
    Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Zaino RJ; Brady WE; Todd W; Leslie K; Fischer EG; Horowitz NS; Mannel RS; Walker JL; Ivanovic M; Duska LR
    Int J Gynecol Pathol; 2014 Nov; 33(6):543-53. PubMed ID: 25272292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.
    Saegusa M; Okayasu I
    J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.
    Palacios J; Catasús L; Moreno-Bueno G; Matias-Guiu X; Prat J; Gamallo C
    Virchows Arch; 2001 May; 438(5):464-9. PubMed ID: 11407474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
    van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
    Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization of beta-catenin in normal and carcinogenic endometrium.
    Nei H; Saito T; Yamasaki H; Mizumoto H; Ito E; Kudo R
    Mol Carcinog; 1999 Jul; 25(3):207-18. PubMed ID: 10411147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
    Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
    Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
    Gamallo C; Palacios J; Moreno G; Calvo de Mora J; Suárez A; Armas A
    Am J Pathol; 1999 Aug; 155(2):527-36. PubMed ID: 10433945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas.
    Shih HC; Shiozawa T; Miyamoto T; Uchikawa J; Feng Y; Kashima H; Nikaido T; Konishi I
    Anticancer Res; 2003; 23(5A):3749-54. PubMed ID: 14666673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.
    Wang Y; van der Zee M; Fodde R; Blok LJ
    Oncotarget; 2010 Nov; 1(7):674-684. PubMed ID: 21317462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.